New Orleans, LA - A study conducted by a team of researchers at LSU Health New Orleans has shown for the first time that chronic exposure to inhaled nicotine alone increases blood pressure (hypertension), in both the body's general circulation and in the lungs that can lead to pulmonary hypertension. The study also found that nicotine-induced pulmonary hypertension is accompanied by changes in the size, shape and function (remodeling) of the blood vessels in the lung and the right lower chamber of the heart. Results are published in the May 2020 issue of Hypertension, available here.
Although cigarette smoking is the single most important risk factor for developing cardiovascular and lung diseases, the role of nicotine in the development of disease has not been well understood. The researchers used a novel nicotine inhalation model in mice that closely mimics human smokers/e-cigarette users to examine the effects of chronic nicotine inhalation on the development of cardiovascular and pulmonary disease with a focus on blood pressure and cardiac remodeling.
The researchers documented that nicotine inhalation increased systemic systolic and diastolic blood pressure as early as the first week of exposure.
"The increase was transient, but was sufficiently long to pose potential health risks in individuals with preexisting cardiopulmonary conditions," notes Eric Lazartigues, PhD, Professor of Pharmacology at LSU Health New Orleans School of Medicine.
Pulmonary hypertension is also often associated with remodeling of the blood vessels of the lung. The study findings suggest that chronic nicotine inhalation leads to muscularization of previously non-muscular pulmonary arterioles (small branches of arteries leading to capillaries) consistent with increased right ventricular systolic pressure and pulmonary vascular resistance.
Right ventricle failure is a major cause of death in pulmonary hypertension. The researchers found an eight-week exposure to nicotine resulted in significantly higher right ventricular systolic pressure, as well as thickening of the walls and enlargement of the right ventricle.
"Interestingly, the adverse effects of inhaled nicotine are largely isolated to the right heart, as we found no significant changes in left heart remodeling or protein expression," adds Xinping Yue, MD, PhD, Assistant Professor of Physiology at LSU Health New Orleans School of Medicine.
According to the Centers for Disease Control and Prevention, tobacco use is the leading cause of preventable disease, disability, and death in the United States. Based on 2018 data, about 34 million US adults smoke cigarettes. Every day, about 2,000 young people under age 18 years smoke their first cigarette, and more than 300 begin smoking cigarettes daily. Over 16 million people live with at least one disease caused by smoking, and 58 million nonsmoking Americans are exposed to secondhand smoke. In 2017, 25.2% of Louisiana high school youth reported currently using any tobacco product, including e-cigarettes. Among Louisiana high school youth, 12.3% reported currently smoking cigarettes.
"There is a frightening trend of increasing usage of e-cig and vape products in youths and young adults," says Jason Gardner, PhD, Associate Professor of Physiology at LSU Health New Orleans School of Medicine. "Recent high-profile cases of hospitalization and death following e-cig usage necessitate a greater understanding regarding the health impact of inhaled nicotine delivery systems. The current study clearly demonstrates the adverse effects of nicotine on both systemic and pulmonary blood pressure and cardiac remodeling. This study should help raise the awareness of the adverse effects of nicotine inhalation on the cardiopulmonary system and help formulate public health policies on e-cigarettes."
The LSU Health New Orleans research team also included Joshua Oakes, PhD, Postdoctoral Fellow; Jiaxi Xu, PhD, Postdoctoral Fellow; Tamara Morris, BS, Research Associate; Nicholas Fried, BS, MD/PhD student; Charlotte Pearson, undergraduate student; Thomas Lobell, MS, Research Associate; and Nicholas Gilpin, PhD, Professor of Physiology.
This study was supported in part by research grants from the National Institute of Health and the Department of Veterans Affairs.
LSU Health Sciences Center New Orleans educates Louisiana's health care professionals. The state's flagship health sciences university, LSU Health New Orleans includes a School of Medicine with branch campuses in Baton Rouge and Lafayette, the state's only School of Dentistry, Louisiana's only public School of Public Health, and Schools of Allied Health Professions, Nursing, and Graduate Studies. LSU Health New Orleans faculty take care of patients in public and private hospitals and clinics throughout the region. In the vanguard of biosciences research in a number of areas in a worldwide arena, the LSU Health New Orleans research enterprise generates jobs and enormous economic impact. LSU Health New Orleans faculty have made lifesaving discoveries and continue to work to prevent, advance treatment, or cure disease. To learn more, visit http://www.lsuhsc.edu, http://www.twitter.com/LSUHealthNO, or http://www.facebook.com/LSUHSC.